Production of nitric oxide, lipid peroxidation and oxidase activity of ceruloplasmin in blood of elderly patients with primari hypertension. Effects of perindopril treatment

Aging Clinical and Experimental Research

Volumn 18, Issue 1, 2006, Pages 1-6

  Kedziora Kornatowska, Kornelia ^a   Kornatowski, Tomasz ^a   Bartosz, Grzegorz ^b   Pawluk, Hanna ^a   Czuczejko, Jolanta ^a   Kedziora, Józef ^a   Szadujkis Szadurski, Leszek ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

Author keywords

Aging; Angiotensin converting enzyme inhibitor; Antioxidant system; Nitric Oxide; Oxidative stress; Primary hypertension

Indexed keywords

CERULOPLASMIN; MALONALDEHYDE; NITRATE; NITRIC OXIDE; NITRITE; OXIDOREDUCTASE; PERINDOPRIL; THIOBARBITURIC ACID;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; CERULOPLASMIN BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; ERYTHROCYTE; FEMALE; HUMAN; HYPERTENSION; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PATHOGENESIS; REFERENCE VALUE; TREATMENT OUTCOME;

EID: 33645646751     PISSN: 15940667     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03324634     Document Type: Article

References (30)

1. Kannel W, Gordon T, Schwartz MJ. Systolic versus diastolic blood pressure and risk of coronary artery disease: the Framingham Study. Am J Cardiol 1971; 27: 335-46.
2. Forette B. Hypertension in very old subjects. Clin Exp Hypertens 1999; 21: 917-25.
3. Soltis EF. Effect of age on blood pressure and membrane dependent vascular responses in the rat. Circ Res 1987; 61: 889-97.
4. Taddei S, Virdis A, Mattei P, et al. Aging and endothelial function in normotensive subjects and essential hypertensive patients. Circulation 1995; 91: 1981-7.
5. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956; 11: 298-300.
6. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000; 87: 840-4.
7. Zalba G, Beaumont FJ, San Jose G, Fortuno A, Fortuno MA, Diez J. Is the balance between nitric oxide and superoxide altered in spontaneously hypertensive rats with endothelial dysfunction? Nephrol Dial Transplant 2001; 16 (Suppl 1): 2-5.
8. Li PF, Dietz R, von Harsdorf R. Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells. Circulation 1997; 96: 3602-9.
9. Romero JC, Reckelhoff JF. Role of angiotensin and oxidative stress in essential hypertension. Hypertension 1999; 34 (Part 2): 943-9.
10. Kajda G, Harrison D. Interactions between NO and reactive oxygen species pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res 1999; 43: 562-71.
11. Liao DF, Chen X. Prostacyclin-mediated protection by angiotensin-converting enzyme inhibitors against injury of aortic endothelium by free-radicals. Cardioscience 1992; 3: 79-84.
12. Bartosz M, Kedziora J, Bartosz G. Antioxidant and prooxidant properties of captopril and enalapril. Free Rad Biol Med 1997; 23: 729-35.
13. Fox PL, Mazurrider P, Ehrenwald E, Mukhopadyay CK. Ceruloplasmin and cardiovascular disease. Free Rad Biol Med 2000; 12: 1735-47.
14. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Preassure. JAMA 2003; 289: 2560-72.
15. Ravin H. An improved colorimetric enzymatic assay of ceruloplasmin. J Lab Clin Med 1961; 58/1: 161-8.
16. Placer Z, Cushiman Z, Jonson B. Estimation of products of lipid peroxidation, malondialdehyde, in biochemical systems. Anal Biochem 1966; 16: 359-64.
17. Marletta MA, Yoon PS, Iyengar R, Leaf CD, Wishnok JS. Macrophage oxidation of L-arginine to nitrite and nitrate. Nitric oxide is an intermediate. Biochemistry 1988; 27: 8706-11.
18. Pryor WA. Oxy-radicals and related species: their formation, lifetimes and reactions. Annu Rev Physiol 1986; 48: 209-14.
19. Kocemba J, Gryglewska B, Klich A, Grodzicki T. Distribution of blood pressure and prevalence of arterial hypertension in the old population of Cracow. Mat Med Pol 1991; 1: 33-5.
20. Schöneich C. Reactive oxygen species and biological aging: a mechanistic approach. Exp Gerontol 1999; 34: 19-34.
21. Gil P, Farinas F, Casado, A, Lopez-Fernandez E. Malondialdehyde: possible marker of aging. Gerontology 2002; 48: 209-14.
22. Ershler WB, Keller FT. Age-associated increased interleukin 6 gene expression, late-life diseases and frailty. Annu Rev Med 2000; 51: 245-70.
23. Cutler RG. Antioxidants and aging. Am J Clin Nutr 2002; 53: 373S-9S.
24. Ruiz-Ortega M, Lorenzo O, Ruperez M, et al. Role of the renin-angiotensin system in vascular diseases. Expanding the field. Hypertension 2001; 38: 1382-7.
25. Messerli FH, Ventura HO, Glade LB, Sundgaard-Rjise K, Dunn FG, Frohlich ED. Essential hypertension in the elderly: hemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels. Lancet 1983; 29: 983-5.
26. Anderson S. Ageing and the renin-angiotensin system. Nephrol Dial Transplant 1997; 12: 1093-4.
27. Kohno M, Yokokawa K, Minami M, et al. Plasma levels of nitric oxide and related vasoactive factors following long term treatment with angiotensin-converting enzyme inhibitor in patients with essential hypertension. Metabolism 1999; 48: 1256-9.
28. Kedziora-Komatowska K, Luciak M. Effect of angiotensin convertase inhibitors on lipid peroxidation and peroxyl radical-trapping capacity in rats with experimental diabetes. Biochem Mol Biol Int 1998; 42: 246-9.
29. Dijordjevic VB, Pavlovic D, Pejovic M, Cvetkovic T, Lecic N, Dejmanin IM. Changes of lipid peroxidation and antioxidative factors level in blood of patients treated with ACE inhibitors. Clin Nephrol 1997; 47: 243-7.
30. Hayek T, Attias J, Colemon R, et al. The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice. Cardiovasc Res 1999; 44: 579-87.